Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Molecular Brain Research
- Vol. 79 (1-2) , 150-155
- https://doi.org/10.1016/s0169-328x(00)00095-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Negative regulation of brain-derived neurotrophic factor mRNA expression by kainic acid in substantia nigra.Molecular Brain Research, 1999
- BDNF gene transcripts in mesencephalic neurons and its differential regulation by NMDANeuroReport, 1998
- Neurotrophin-6 is a new member of the nerve growth factor familyNature, 1994
- Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine LesionsJournal of Neurochemistry, 1994
- Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalonJournal of Neuroscience, 1994
- Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.Proceedings of the National Academy of Sciences, 1992
- Neurotrophin-5: A novel neurotrophic factor that activates trk and trkBNeuron, 1991
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991
- Reversal of Experimental Parkinsonism by Lesions of the Subthalamic NucleusScience, 1990
- Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkeyBrain Research, 1979